Insulin resistance in secondary hypertension - PubMed (original) (raw)
Comparative Study
doi: 10.1093/ajh/5.1.26.
Affiliations
- PMID: 1736930
- DOI: 10.1093/ajh/5.1.26
Comparative Study
Insulin resistance in secondary hypertension
A Shamiss et al. Am J Hypertens. 1992 Jan.
Abstract
The insulin sensitivity of five essential hypertensive patients was compared to five patients with renovascular hypertension, five patients with primary hyperaldosteronism, and five normotensive subjects, using the euglycemic hyperinsulinemic clamp technique. Essential hypertensive patients had significantly lower insulin sensitivity than patients with hyperaldosteronism and renovascular hypertensive patients (P = .0066, P = .004, respectively). Hyperaldosteronism patients also had less insulin sensitivity than renovascular hypertensive patients (P = .016). A significant negative correlation was found between body mass index and insulin sensitivity index for essential hypertension patients only (r = -0.87, P less than .003). No such correlation was found in the secondary hypertension patients. The findings suggest a causal relationship between insulin resistance and the development of essential hypertension. Secondary hypertension, on the other hand, is not such an insulin resistant state.
Similar articles
- Insulinemia and blood pressure. Relationships in patients with primary and secondary hypertension, and with or without glucose metabolism impairment.
Marigliano A, Tedde R, Sechi LA, Pala A, Pisanu G, Pacifico A. Marigliano A, et al. Am J Hypertens. 1990 Jul;3(7):521-6. doi: 10.1093/ajh/3.7.521. Am J Hypertens. 1990. PMID: 2194508 Review. - Impaired insulin action in primary hyperaldosteronism.
Widimský J Jr, Sindelka G, Haas T, Prázný M, Hilgertová J, Skrha J. Widimský J Jr, et al. Physiol Res. 2000;49(2):241-4. Physiol Res. 2000. PMID: 10984090 - Comparison of the insulin action parameters from hyperinsulinemic clamps with homeostasis model assessment and QUICKI indexes in subjects with different endocrine disorders.
Skrha J, Haas T, Sindelka G, Prázný M, Widimský J, Cibula D, Svacina S. Skrha J, et al. J Clin Endocrinol Metab. 2004 Jan;89(1):135-41. doi: 10.1210/jc.2002-030024. J Clin Endocrinol Metab. 2004. PMID: 14715840 - Decreased Homocysteine Trans-Sulfuration in Hypertension With Hyperhomocysteinemia: Relationship With Insulin Resistance.
Tessari P, Cecchet D, Vettore M, Coracina A, Puricelli L, Kiwanuka E. Tessari P, et al. J Clin Endocrinol Metab. 2018 Jan 1;103(1):56-63. doi: 10.1210/jc.2017-01076. J Clin Endocrinol Metab. 2018. PMID: 29029082 - Does insulin have a role in hypertension?
Bursztyn M. Bursztyn M. Blood Press Suppl. 1996;1:64-6. Blood Press Suppl. 1996. PMID: 9162441 Review.
Cited by
- Genetics of Cd36 and the clustering of multiple cardiovascular risk factors in spontaneous hypertension.
Pravenec M, Zidek V, Simakova M, Kren V, Krenova D, Horky K, Jachymova M, Mikova B, Kazdova L, Aitman TJ, Churchill PC, Webb RC, Hingarh NH, Yang Y, Wang JM, Lezin EM, Kurtz TW. Pravenec M, et al. J Clin Invest. 1999 Jun;103(12):1651-7. doi: 10.1172/JCI6691. J Clin Invest. 1999. PMID: 10377171 Free PMC article. - The effect of aldosterone on glucose metabolism.
Corry DB, Tuck ML. Corry DB, et al. Curr Hypertens Rep. 2003 Apr;5(2):106-9. doi: 10.1007/s11906-003-0065-2. Curr Hypertens Rep. 2003. PMID: 12642008 Review. - Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.
Baba T, Neugebauer S, Watanabe T. Baba T, et al. Drugs. 1997 Aug;54(2):197-234. doi: 10.2165/00003495-199754020-00002. Drugs. 1997. PMID: 9257079 Review. - Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.
Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Steinberg HO, et al. J Clin Invest. 1996 Jun 1;97(11):2601-10. doi: 10.1172/JCI118709. J Clin Invest. 1996. PMID: 8647954 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical